Acute leukemia during pregnancy: A single institutional experience with 17 cases

L. J S Greenlund, L. Letendre, Ayalew Tefferi

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

We reviewed the medical records of 17 consecutive patients with concomitant acute leukemia and pregnancy seen at our institution over a 37-year period. Fifteen cases each were either newly diagnosed or classified as acute myeloid leukemia (AML). Seven diagnoses (41%) occurred in the first, 7 (41%) in the second, and 3 (18%) in the third trimester. In general, nine patients received chemotherapy while pregnant-eight in the second trimester and one in the third. The overall complete remission rate among the 13 patients with newly diagnosed AML was 69%, compared with 86% in those who were pregnant during chemotherapy. Long-term survival was documented in five of the nine complete responders. Three of four patients who elected to delay treatment until after delivery died within days of starting chemotherapy. Unintentional fetal loss occurred in four patients (29%), including two without exposure to chemotherapy. There were no instances of congenital malformation. The results from the current study confirm that pregnancy per se may not affect the outcome of chemotherapy in AML. In addition, it is suggested that treatment delays may compromise maternal outcome without improving pregnancy outcome.

Original languageEnglish (US)
Pages (from-to)571-577
Number of pages7
JournalLeukemia and Lymphoma
Volume41
Issue number5-6
StatePublished - 2001

Fingerprint

Leukemia
Drug Therapy
Pregnancy
Acute Myeloid Leukemia
Third Pregnancy Trimester
Second Pregnancy Trimester
Pregnancy Outcome
Medical Records
Mothers
Survival
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Chemotherapy
  • Pregnancy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Acute leukemia during pregnancy : A single institutional experience with 17 cases. / Greenlund, L. J S; Letendre, L.; Tefferi, Ayalew.

In: Leukemia and Lymphoma, Vol. 41, No. 5-6, 2001, p. 571-577.

Research output: Contribution to journalArticle

Greenlund, L. J S ; Letendre, L. ; Tefferi, Ayalew. / Acute leukemia during pregnancy : A single institutional experience with 17 cases. In: Leukemia and Lymphoma. 2001 ; Vol. 41, No. 5-6. pp. 571-577.
@article{0623f7bfb72847948a228462207210ba,
title = "Acute leukemia during pregnancy: A single institutional experience with 17 cases",
abstract = "We reviewed the medical records of 17 consecutive patients with concomitant acute leukemia and pregnancy seen at our institution over a 37-year period. Fifteen cases each were either newly diagnosed or classified as acute myeloid leukemia (AML). Seven diagnoses (41{\%}) occurred in the first, 7 (41{\%}) in the second, and 3 (18{\%}) in the third trimester. In general, nine patients received chemotherapy while pregnant-eight in the second trimester and one in the third. The overall complete remission rate among the 13 patients with newly diagnosed AML was 69{\%}, compared with 86{\%} in those who were pregnant during chemotherapy. Long-term survival was documented in five of the nine complete responders. Three of four patients who elected to delay treatment until after delivery died within days of starting chemotherapy. Unintentional fetal loss occurred in four patients (29{\%}), including two without exposure to chemotherapy. There were no instances of congenital malformation. The results from the current study confirm that pregnancy per se may not affect the outcome of chemotherapy in AML. In addition, it is suggested that treatment delays may compromise maternal outcome without improving pregnancy outcome.",
keywords = "Acute myeloid leukemia, Chemotherapy, Pregnancy",
author = "Greenlund, {L. J S} and L. Letendre and Ayalew Tefferi",
year = "2001",
language = "English (US)",
volume = "41",
pages = "571--577",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "5-6",

}

TY - JOUR

T1 - Acute leukemia during pregnancy

T2 - A single institutional experience with 17 cases

AU - Greenlund, L. J S

AU - Letendre, L.

AU - Tefferi, Ayalew

PY - 2001

Y1 - 2001

N2 - We reviewed the medical records of 17 consecutive patients with concomitant acute leukemia and pregnancy seen at our institution over a 37-year period. Fifteen cases each were either newly diagnosed or classified as acute myeloid leukemia (AML). Seven diagnoses (41%) occurred in the first, 7 (41%) in the second, and 3 (18%) in the third trimester. In general, nine patients received chemotherapy while pregnant-eight in the second trimester and one in the third. The overall complete remission rate among the 13 patients with newly diagnosed AML was 69%, compared with 86% in those who were pregnant during chemotherapy. Long-term survival was documented in five of the nine complete responders. Three of four patients who elected to delay treatment until after delivery died within days of starting chemotherapy. Unintentional fetal loss occurred in four patients (29%), including two without exposure to chemotherapy. There were no instances of congenital malformation. The results from the current study confirm that pregnancy per se may not affect the outcome of chemotherapy in AML. In addition, it is suggested that treatment delays may compromise maternal outcome without improving pregnancy outcome.

AB - We reviewed the medical records of 17 consecutive patients with concomitant acute leukemia and pregnancy seen at our institution over a 37-year period. Fifteen cases each were either newly diagnosed or classified as acute myeloid leukemia (AML). Seven diagnoses (41%) occurred in the first, 7 (41%) in the second, and 3 (18%) in the third trimester. In general, nine patients received chemotherapy while pregnant-eight in the second trimester and one in the third. The overall complete remission rate among the 13 patients with newly diagnosed AML was 69%, compared with 86% in those who were pregnant during chemotherapy. Long-term survival was documented in five of the nine complete responders. Three of four patients who elected to delay treatment until after delivery died within days of starting chemotherapy. Unintentional fetal loss occurred in four patients (29%), including two without exposure to chemotherapy. There were no instances of congenital malformation. The results from the current study confirm that pregnancy per se may not affect the outcome of chemotherapy in AML. In addition, it is suggested that treatment delays may compromise maternal outcome without improving pregnancy outcome.

KW - Acute myeloid leukemia

KW - Chemotherapy

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0034895314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034895314&partnerID=8YFLogxK

M3 - Article

C2 - 11378574

AN - SCOPUS:0034895314

VL - 41

SP - 571

EP - 577

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 5-6

ER -